FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382011693> ?p ?o ?g. }

• W4382011693 abstract "Immune therapeutics holds great promise in the treatment of type 1 diabetes (T1D). Nonetheless, their progress is hampered by limited efficacy, equipoise, or issues of safety. To address this, a novel and specific nanodelivery platform for T1D that targets high endothelial venules (HEVs) presented in the pancreatic lymph nodes (PLNs) and pancreas is developed. Data indicate that the pancreata of nonobese diabetic (NOD) mice and patients with T1D are unique in their expression of newly formed HEVs. Anti-CD3 mAb is encapsulated in poly(lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles (NPs), the surfaces of which are conjugated with MECA79 mAb that recognizes HEVs. Targeted delivery of these NPs improves accumulation of anti-CD3 mAb in both the PLNs and pancreata of NOD mice. Treatment of hyperglycemic NOD mice with MECA79-anti-CD3-NPs results in significant reversal of T1D compared to those that are untreated, treated with empty NPs, or provided free anti-CD3. This effect is associated with a significant reduction of T effector cell populations in the PLNs and a decreased production of pro-inflammatory cytokine in the mice treated with MECA79-anti-CD3-NPs. In summary, HEV-targeted therapeutics may be used as a means by which immune therapeutics can be delivered to PLNs and pancreata to suppress autoimmune diabetes effectively." @default.
• W4382011693 created "2023-06-27" @default.
• W4382011693 creator A5001694345 @default.
• W4382011693 creator A5005281317 @default.
• W4382011693 creator A5006307856 @default.
• W4382011693 creator A5007087886 @default.
• W4382011693 creator A5014200077 @default.
• W4382011693 creator A5019438195 @default.
• W4382011693 creator A5023494315 @default.
• W4382011693 creator A5025270532 @default.
• W4382011693 creator A5027205126 @default.
• W4382011693 creator A5027542245 @default.
• W4382011693 creator A5028314110 @default.
• W4382011693 creator A5030177789 @default.
• W4382011693 creator A5039023347 @default.
• W4382011693 creator A5048187754 @default.
• W4382011693 creator A5050108132 @default.
• W4382011693 creator A5053514281 @default.
• W4382011693 creator A5056054628 @default.
• W4382011693 creator A5060145442 @default.
• W4382011693 creator A5061721392 @default.
• W4382011693 creator A5073250812 @default.
• W4382011693 creator A5076358991 @default.
• W4382011693 creator A5086534495 @default.
• W4382011693 creator A5092262227 @default.
• W4382011693 date "2023-08-16" @default.
• W4382011693 modified "2023-10-17" @default.
• W4382011693 title "Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes" @default.
• W4382011693 cites W1495690038 @default.
• W4382011693 cites W1510928501 @default.
• W4382011693 cites W1522730425 @default.
• W4382011693 cites W1641258807 @default.
• W4382011693 cites W1841179232 @default.
• W4382011693 cites W1916911965 @default.
• W4382011693 cites W1970942128 @default.
• W4382011693 cites W1971836810 @default.
• W4382011693 cites W1978147073 @default.
• W4382011693 cites W1980516673 @default.
• W4382011693 cites W1983023441 @default.
• W4382011693 cites W1983718760 @default.
• W4382011693 cites W1984014273 @default.
• W4382011693 cites W1984548348 @default.
• W4382011693 cites W1988078074 @default.
• W4382011693 cites W1988573538 @default.
• W4382011693 cites W1988885861 @default.
• W4382011693 cites W1991362116 @default.
• W4382011693 cites W1995043914 @default.
• W4382011693 cites W1995082650 @default.
• W4382011693 cites W1995139895 @default.
• W4382011693 cites W1998035513 @default.
• W4382011693 cites W2000001040 @default.
• W4382011693 cites W2009805582 @default.
• W4382011693 cites W2011450045 @default.
• W4382011693 cites W2012260545 @default.
• W4382011693 cites W2015876690 @default.
• W4382011693 cites W2017001609 @default.
• W4382011693 cites W2018213747 @default.
• W4382011693 cites W2027498388 @default.
• W4382011693 cites W2028616204 @default.
• W4382011693 cites W2035220028 @default.
• W4382011693 cites W2036932527 @default.
• W4382011693 cites W2041277162 @default.
• W4382011693 cites W2042952613 @default.
• W4382011693 cites W2046620531 @default.
• W4382011693 cites W2049121901 @default.
• W4382011693 cites W2050327470 @default.
• W4382011693 cites W2061071534 @default.
• W4382011693 cites W2062572904 @default.
• W4382011693 cites W2062573090 @default.
• W4382011693 cites W2064093384 @default.
• W4382011693 cites W2064431167 @default.
• W4382011693 cites W2065020763 @default.
• W4382011693 cites W2074011660 @default.
• W4382011693 cites W2074463323 @default.
• W4382011693 cites W2081864087 @default.
• W4382011693 cites W2094345654 @default.
• W4382011693 cites W2096264324 @default.
• W4382011693 cites W2097593754 @default.
• W4382011693 cites W2098151578 @default.
• W4382011693 cites W2098954537 @default.
• W4382011693 cites W2106473403 @default.
• W4382011693 cites W2110548854 @default.
• W4382011693 cites W2112998064 @default.
• W4382011693 cites W2113981178 @default.
• W4382011693 cites W2114245966 @default.
• W4382011693 cites W2114897901 @default.
• W4382011693 cites W2117127822 @default.
• W4382011693 cites W2121789150 @default.
• W4382011693 cites W2123592823 @default.
• W4382011693 cites W2124063441 @default.
• W4382011693 cites W2124812894 @default.
• W4382011693 cites W2126995684 @default.
• W4382011693 cites W2127788605 @default.
• W4382011693 cites W2128256270 @default.
• W4382011693 cites W2128734761 @default.
• W4382011693 cites W2132160710 @default.
• W4382011693 cites W2132511649 @default.
• W4382011693 cites W2139333712 @default.
• W4382011693 cites W2140213275 @default.
• W4382011693 cites W2143095313 @default.

• next